158 related articles for article (PubMed ID: 25854316)
1. Dose-dependent effect of 2-deoxy-D-glucose on glycoprotein mannosylation in cancer cells.
Ahadova A; Gebert J; von Knebel Doeberitz M; Kopitz J; Kloor M
IUBMB Life; 2015 Mar; 67(3):218-26. PubMed ID: 25854316
[TBL] [Abstract][Full Text] [Related]
2. 2-Deoxyglucose induces the expression of thioredoxin interacting protein (TXNIP) by increasing O-GlcNAcylation - Implications for targeting the Warburg effect in cancer cells.
Hong SY; Hagen T
Biochem Biophys Res Commun; 2015 Oct; 465(4):838-44. PubMed ID: 26315267
[TBL] [Abstract][Full Text] [Related]
3. 2-deoxy D-glucose prevents cell surface expression of NKG2D ligands through inhibition of N-linked glycosylation.
Andresen L; Skovbakke SL; Persson G; Hagemann-Jensen M; Hansen KA; Jensen H; Skov S
J Immunol; 2012 Feb; 188(4):1847-55. PubMed ID: 22227571
[TBL] [Abstract][Full Text] [Related]
4. An Integrated Proteomic and Glycoproteomic Investigation Reveals Alterations in the
Ma C; Tsai HY; Zhang Q; Senavirathna L; Li L; Chin LS; Chen R; Pan S
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897829
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of KIT-glycosylation by 2-deoxyglucose abrogates KIT-signaling and combination with ABT-263 synergistically induces apoptosis in gastrointestinal stromal tumor.
Mühlenberg T; Grunewald S; Treckmann J; Podleska L; Schuler M; Fletcher JA; Bauer S
PLoS One; 2015; 10(3):e0120531. PubMed ID: 25781619
[TBL] [Abstract][Full Text] [Related]
6. Interference of nucleoside diphosphate derivatives of 2-deoxy-D-glucose with the glycosylation of virus-specific glycoproteins in vivo.
Schmidt MF; Schwarz RT; Scholtissek C
Eur J Biochem; 1976 Nov; 70(1):55-62. PubMed ID: 1034557
[TBL] [Abstract][Full Text] [Related]
7. Effects of the inhibitors of IMP dehydrogenase, tiazofurin and mycophenolic acid, on glycoprotein metabolism.
Sokoloski JA; Sartorelli AC
Mol Pharmacol; 1985 Dec; 28(6):567-73. PubMed ID: 2867464
[TBL] [Abstract][Full Text] [Related]
8. 2-Deoxy-D-glucose-induced cytotoxicity and radiosensitization in tumor cells is mediated via disruptions in thiol metabolism.
Lin X; Zhang F; Bradbury CM; Kaushal A; Li L; Spitz DR; Aft RL; Gius D
Cancer Res; 2003 Jun; 63(12):3413-7. PubMed ID: 12810678
[TBL] [Abstract][Full Text] [Related]
9. 2-Deoxy-d-glucose increases GFAT1 phosphorylation resulting in endoplasmic reticulum-related apoptosis via disruption of protein N-glycosylation in pancreatic cancer cells.
Ishino K; Kudo M; Peng WX; Kure S; Kawahara K; Teduka K; Kawamoto Y; Kitamura T; Fujii T; Yamamoto T; Wada R; Naito Z
Biochem Biophys Res Commun; 2018 Jun; 501(3):668-673. PubMed ID: 29753740
[TBL] [Abstract][Full Text] [Related]
10. 2-Deoxy-2-fluoro-D-galactose protein N-glycosylation.
Loch N; Geilen CC; Spörndle I; Oberdorfer F; Keppler D; Tauber R; Reutter W
FEBS Lett; 1991 Dec; 294(3):217-20. PubMed ID: 1756864
[TBL] [Abstract][Full Text] [Related]
11. Chemical inhibitors of hexokinase-2 enzyme reduce lactate accumulation, alter glycosylation processing, and produce altered glycoforms in CHO cell cultures.
Naik HM; Kumar S; Reddy JV; Gonzalez JE; McConnell BO; Dhara VG; Wang T; Yu M; Antoniewicz MR; Betenbaugh MJ
Biotechnol Bioeng; 2023 Sep; 120(9):2559-2577. PubMed ID: 37148536
[TBL] [Abstract][Full Text] [Related]
12. Interference with glycosylation of glycoproteins. Inhibition of formation of lipid-linked oligosaccharides in vivo.
Datema R; Schwarz RT
Biochem J; 1979 Oct; 184(1):113-23. PubMed ID: 534512
[TBL] [Abstract][Full Text] [Related]
13. 2-Deoxy-D-glucose targeting of glucose metabolism in cancer cells as a potential therapy.
Zhang D; Li J; Wang F; Hu J; Wang S; Sun Y
Cancer Lett; 2014 Dec; 355(2):176-83. PubMed ID: 25218591
[TBL] [Abstract][Full Text] [Related]
14. Genetic variance contributes to ingestive processes: a survey of 2-deoxy-D-glucose-induced feeding in eleven inbred mouse strains.
Lewis SR; Ahmed S; Khaimova E; Israel Y; Singh A; Kandov Y; Kest B; Bodnar RJ
Physiol Behav; 2006 Mar; 87(3):595-601. PubMed ID: 16427100
[TBL] [Abstract][Full Text] [Related]
15. Novel actions of 2-deoxy-D-glucose: protection against Shiga toxins and changes in cellular lipids.
Kavaliauskiene S; Skotland T; Sylvänne T; Simolin H; Klokk TI; Torgersen ML; Lingelem AB; Simm R; Ekroos K; Sandvig K
Biochem J; 2015 Aug; 470(1):23-37. PubMed ID: 26251444
[TBL] [Abstract][Full Text] [Related]
16. Antiproliferative activity in vitro and in vivo of the spicamycin analogue KRN5500 with altered glycoprotein expression in vitro.
Burger AM; Kaur G; Hollingshead M; Fischer RT; Nagashima K; Malspeis L; Duncan KL; Sausville EA
Clin Cancer Res; 1997 Mar; 3(3):455-63. PubMed ID: 9815705
[TBL] [Abstract][Full Text] [Related]
17. Properties of a baby-hamster-kidney cell line with increased resistance of 2-deoxy-D-glucose.
Meager A; Nairin R; Hughes RC
Eur J Biochem; 1977 Jan; 72(2):275-81. PubMed ID: 837919
[TBL] [Abstract][Full Text] [Related]
18. 2-Deoxy-d-Glucose-Induced Metabolic Alteration in Human Oral Squamous SCC15 Cells: Involvement of N-Glycosylation of Axl and Met.
Lee N; Jang WJ; Seo JH; Lee S; Jeong CH
Metabolites; 2019 Sep; 9(9):. PubMed ID: 31533338
[TBL] [Abstract][Full Text] [Related]
19. Effect of 2-deoxy-D-glucose on the cell-surface glycoproteins of hamster fibroblasts,
Hughes RC; Meager A; Nairn R
Eur J Biochem; 1977 Jan; 72(2):265-73. PubMed ID: 837918
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of 2-deoxy-D-glucose inhibition of cell-wall polysaccharide and glycoprotein biosyntheses in Saccharomyces cerevisiae.
Krátký Z; Biely P; Bauer S
Eur J Biochem; 1975 Jun; 54(2):459-67. PubMed ID: 1100378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
